AI-generated summary
The authors retrospectively reviewed 227 vitiligo patches in 142 patients treated with excimer light twice weekly, with repigmentation assessed by two dermatologists. They report that 30.0% of patches achieved more than 50% repigmentation, and that fewer sessions, segmental lesions and absence of melasma predicted poor response. The authors describe excimer light as valuable even after prior treatment failure, but the retrospective design limits certainty.
- Participants
- 142
- Who or what was studied
- Patients with segmental or non-segmental vitiligo in Taiwan, including some who had failed previous treatments
- Limits stated in the abstract
- The study is retrospective, so it cannot establish causation or compare against a control group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.